Patents Represented by Attorney Wilson Sonsini Goodrich & Rosati
  • Patent number: 8298549
    Abstract: Methods for generating immune responses using adenovirus vectors that allow multiple vaccinations with the same adenovirus vector and vaccinations in individuals with preexisting immunity to adenovirus are provided.
    Type: Grant
    Filed: January 4, 2010
    Date of Patent: October 30, 2012
    Assignee: Etubics Corporation
    Inventors: Joseph P. Balint, Frank R. Jones, Richard B. Gayle, III
  • Patent number: 8299307
    Abstract: Provided are alkynyl phenyl derivative compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.
    Type: Grant
    Filed: June 30, 2008
    Date of Patent: October 30, 2012
    Assignee: Acucela Inc.
    Inventors: Ian Leslie Scott, Vladimir Aleksandrovich Kuksa, Mark W Orme, Thomas Little, Anna Gall, Jennifer Gage, Feng Hong
  • Patent number: 8298339
    Abstract: Apparatuses and methods are provided for the continuous, roll-to-roll formation of photovoltaic (PV) cells. Apparatuses include reel-to-reel transport chambers, one or more deposition chambers, a differential process isolation unit and a chamber for obtaining real time quality data, including IV data, yield data and uniformity data.
    Type: Grant
    Filed: August 4, 2009
    Date of Patent: October 30, 2012
    Assignee: Xunlight Corporation
    Inventors: Aarohi Vijh, Xinmin Cao, Bradley S. Mohring
  • Patent number: 8299112
    Abstract: Described herein are compounds that are estrogen receptor modulators. Also described are pharmaceutical compositions and medicaments that include the compounds described herein, as well as methods of using such estrogen receptor modulators, alone and in combination with other compounds, for treating diseases or conditions that are mediated or dependent upon estrogen receptors.
    Type: Grant
    Filed: September 15, 2011
    Date of Patent: October 30, 2012
    Assignee: Aragon Pharmaceuticals, Inc.
    Inventors: Nicholas D. Smith, Mehmet Kahraman, Steven P. Govek, Johnny Y. Nagasawa, Andiliy G. Lai, Jackaline D. Julien, Celine Bonnefous
  • Patent number: 8298856
    Abstract: A reverse p-n junction solar cell device and methods for forming the reverse p-n junction solar cell device are described. A variety of n-p junction and reverse p-n junction solar cell devices and related methods of manufacturing are provided. N-intrinsic-p junction and reverse p-intrinsic-n junction solar cell devices are also described.
    Type: Grant
    Filed: July 17, 2009
    Date of Patent: October 30, 2012
    Assignee: Uriel Solar, Inc.
    Inventor: James David Garnett
  • Patent number: 8298765
    Abstract: Compositions and methods are provided for constructing multi-functional nucleic acid nano-structures. Nano-structures are provided incorporating a built-in modularity, including nucleic acid modules. Modules contain moieties including detectible labels, nanoparticles, reactive moieties and other functional groups. Nano-structures can be used for delivery of target compounds, as well as identification of target nucleic acid molecules.
    Type: Grant
    Filed: December 31, 2009
    Date of Patent: October 30, 2012
    Assignee: Cornell University
    Inventors: Dan Luo, Jong Bum Lee
  • Patent number: 8292805
    Abstract: An illuminated suction apparatus including a hand-held surgical device combining a high-performance illumination waveguide with suction. This device would be useful in a wide array of various surgical procedures including open and minimally invasive orthopedics.
    Type: Grant
    Filed: November 10, 2009
    Date of Patent: October 23, 2012
    Assignee: Invuity, Inc.
    Inventors: Alex Vayser, Fernando Erismann, Kenneth B. Trauner, Jonathan Gasson, Derrick Richardson
  • Patent number: 8292847
    Abstract: A system and method for regenerating damaged or necrosed tissue. Negative or vacuum pressure is applied to a surface of the damaged tissue to stimulate the revascularization of the area and/or increased blood flow to the area, which encourages the regeneration of the damaged tissue. A negative pressure device is provided that is capable of providing a sequenced vacuum treatment regimen to damaged tissue.
    Type: Grant
    Filed: December 24, 2008
    Date of Patent: October 23, 2012
    Assignee: Raptor Ridge, LLC
    Inventor: William K. Wheeler
  • Patent number: 8293489
    Abstract: Methods and compositions are provided for detection of biological substances in nasal specimen.
    Type: Grant
    Filed: January 31, 2008
    Date of Patent: October 23, 2012
    Inventor: Robert I. Henkin
  • Patent number: 8295523
    Abstract: A hearing aid device for placement in an ear of a user includes an elongate support and a transducer. The elongate support has a proximal portion and a distal end, and the transducer is attached to the elongate support near the distal end. The support is adapted to position the transducer near an eardrum while the proximal portion is placed at the location near an ear canal opening. The elongate support is sized to minimize contact with the ear between the proximal portion and distal end. The elongate support permits sound waves to travel along the ear canal. In some embodiments, a microphone is positioned in the ear canal along the support, for example inside the support, to provide directionally dependent sound localization cues, and the transducer on the distal end of the elongate support comprises a coil assembly coupled to a magnet positioned on the tympanic membrane.
    Type: Grant
    Filed: October 2, 2008
    Date of Patent: October 23, 2012
    Assignee: Soundbeam LLC
    Inventors: Jonathan P. Fay, Sunil Puria, Paul Rucker, John H. Winstead, Rodney C. Perkins
  • Patent number: 8295359
    Abstract: Provided herein are processes, systems and devices for reducing differentials in visual media. Undesired differentials include undesired contrasts in brightness and/or color. Also described herein are signals, video frames and video streams that have been limited to produce a desired differential. Further described are methods for reducing triggers that can lead to migraines, nausea and neuronal paroxysms in viewers of visual media.
    Type: Grant
    Filed: March 18, 2008
    Date of Patent: October 23, 2012
    Assignee: Auratechnic, Inc.
    Inventors: Linda Farmer, Jon Rolph
  • Patent number: 8293794
    Abstract: The present invention provides novel methods and compositions for the treatment and prevention of CNS-related conditions. One of the CNS-related conditions treated by the methods and compositions of the invention is Alzheimer's disease.
    Type: Grant
    Filed: April 2, 2010
    Date of Patent: October 23, 2012
    Assignee: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Timothy J. Fultz, Laurence R. Meyerson
  • Patent number: 8288354
    Abstract: Small interfering RNA (siRNA) knock down antisense transcripts, and regulate the expression of their sense partners. This regulation can either be discordant (antisense knockdown results in sense transcript elevation) or concordant (antisense knockdown results in concomitant sense transcript reduction).
    Type: Grant
    Filed: December 28, 2006
    Date of Patent: October 16, 2012
    Assignee: The Scripps Research Institute
    Inventor: Claes Wahlestedt
  • Patent number: 8288127
    Abstract: The present invention provides an improved expression system for the production of recombinant polypeptides utilizing auxotrophic selectable markers. In addition, the present invention provides improved recombinant protein production in host cells through the improved regulation of expression.
    Type: Grant
    Filed: July 30, 2009
    Date of Patent: October 16, 2012
    Assignee: Pfenex, Inc
    Inventors: Jane C. Schneider, Lawrence C. Chew, Anne Kathryn Badgley, Thomas Martin Ramseier
  • Patent number: 8283369
    Abstract: Described herein are compounds useful in the modulation of blood uric acid levels, formulations containing them and methods of using them. In some embodiments, the compounds described herein are used in the treatment or prevention of disorders related to aberrant levels of uric acid.
    Type: Grant
    Filed: June 30, 2011
    Date of Patent: October 9, 2012
    Assignee: Ardea Biosciences. Inc.
    Inventors: Barry D. Quart, Jean-Luc Girardet, Esmir Gunic, Li-Tain Yeh
  • Patent number: 8283314
    Abstract: Dermatological and cosmetic compositions and methods are provided to reduce the appearance of biological and/or environmentally-caused aging.
    Type: Grant
    Filed: July 2, 2008
    Date of Patent: October 9, 2012
    Assignee: Jan Marini Skin Research, Inc.
    Inventor: Jan Marini
  • Patent number: 8281786
    Abstract: The present invention provides a method and apparatus for controlling a patient's body temperature and in particular for inducing therapeutic hypothermia. Various embodiments of the system are described. The system includes: a source of breathing gas, which may be in the form of a compressed breathing gas mixture; a heat exchanger or other heating and/or cooling device; and a breathing interface, such as a breathing mask or tracheal tube. Optionally, the system may include additional features, such as a mechanical respirator, a nebulizer for introducing medication into the breathing gas, a body temperature probe and a feedback controller. The system can use air or a specialized breathing gas mixture, such as He/O2 or SF/O2 to increase the heat transfer rate. In addition, the system may include an ice particle generator for introducing fine ice particles into the flow of breathing gas to further increase the heat transfer rate.
    Type: Grant
    Filed: November 11, 2008
    Date of Patent: October 9, 2012
    Assignee: Thermocure, Inc.
    Inventor: Amir Belson
  • Patent number: 8283379
    Abstract: The present invention provides novel methods and compositions for the treatment and prevention of CNS-related conditions. One of the CNS-related conditions treated by the methods and compositions of the invention is Alzheimer's disease.
    Type: Grant
    Filed: April 9, 2010
    Date of Patent: October 9, 2012
    Assignee: Adamas Pharmaceuticals, Inc.
    Inventors: Gregory T. Went, Timothy J. Fultz, Laurence R. Meyerson
  • Patent number: 8283460
    Abstract: Methods, compositions, and kits that include small hairpin RNA (shRNA) useful for inhibition of gene expression, such as viral-mediated gene expression, are described.
    Type: Grant
    Filed: October 14, 2009
    Date of Patent: October 9, 2012
    Assignee: Somagenics, Inc.
    Inventors: Qing Ge, Brian H. Johnston, Sergei A. Kazakov, Heini Ilves, Anne Dallas
  • Patent number: 8285093
    Abstract: A microstructure optical adapter or tip according to the present disclosure may incorporate precision micro structure optical components engaging the input or output end of light energy delivery devices for customized light delivery of the light energy. The incorporation of precision micro structure optical components in injection molded plastic or glass parts will allow for inexpensive modification of the output light while also serving to protect the end of the illumination device. The micro structure optical components may also be incorporated in an adapter to tailor the light energy to the subsequent device.
    Type: Grant
    Filed: January 6, 2009
    Date of Patent: October 9, 2012
    Assignee: Invuity, Inc.
    Inventors: Alex Vayser, Kenneth C. Trauner